emu Regional Benefits Study Advancing
Filed with ASX · · 3 pages · English
Summary by 6ix AI
Emvision Medical Devices Ltd. reports on the progress of its emu Regional Benefits Study, highlighting the completion of site visits and the advancement of study protocols. The study aims to demonstrate the clinical benefits of the emu bedside scanner in regional hospitals lacking CT access, with a focus on improving stroke diagnosis. A progress payment has been received under the Cooperative Research Centres Projects program, supporting the study's objectives. Next steps include finalizing the study protocol and obtaining necessary approvals for further site inclusion.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
EMvision Medical Devices Ltd. on 6ix
Story so far
Earlier from EMvision Medical Devices
- emu Pivotal Trial Recruitment Surpasses 200 Patients
- Appendix 4E & Annual Report to 30 June 2026
- FY26 Results Presentation
- Appendix 4G & Corporate Governance Statement
- Change of Registered Office Address
Later from EMvision Medical Devices
- Notification regarding unquoted securities - EMV
- First Responder Successfully Trialled with MSU
- $4.3m Non-Dilutive R&D Tax Rebate Received
- Date of AGM & Closing Date of Director Nominations
- Mayo Clinic emu Early Clinical Experience Presentation
Follow EMvision Medical Devices into a list and get an email when it puts out news.
Follow EMvision Medical Devices